Proliferation of B cell malignancies in all stages of differentiation upon stimulation in the 'CD40 system'

Leukemia

Volumn 10, Issue 3, 1996, Pages 488-493

  Planken, E V ^a,b   Dijkstra, N H ^a   Willemze, R ^a   Kluin Nelemans, J C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b C2 R ^*  (Netherlands)

Author keywords

CD40 system; CLL; MM; NHL; Proliferation

Indexed keywords

CD40 ANTIGEN; FC RECEPTOR; TRITIUM;

ANIMAL CELL; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE DIFFERENTIATION; CANCER GRADING; CELL COUNT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CROSS LINKING; DNA SYNTHESIS; FIBROBLAST CULTURE; FLOW CYTOMETRY; FOLLICULAR LYMPHOMA; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; IMMUNOCYTOMA; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0029981664     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Banchereau J, Rousset F. Growing human B lymphocytes in the CD40 system. Nature 1991; 353: 678-679.
2. Rousset F, Garcia E, Banchereau J. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med 1991; 173: 705-710.
3. Banchereau J, de Paoli P, Vallé A, Garcia E, Rousset F. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 1991; 251: 70-72.
4. Vallé A, Zuber CE, Defrance T, Djossou O, Rie de M, Banchereau J. Activation of human B lymphocytes through CD40 and interleukin 4. Eur J Immunol 1989; 19: 1463-1467.
5. Wheeler K, Pound JD, Gordon J, Jefferis R. Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor. Eur J Immunol 1993; 23: 1165-1168.
6. Ling NR, Maclennan ICM, Mason DY. B-cell and plasma cell antigens: new and previously defined clusters. In: McMichael AJ (ed). Leucocyte Typing III. White cell Differentiation Antigens. Oxford University Press: Oxford, 1987, pp 302-335.
7. Uckun FM. Regulation of human B-cell ontogeny. Blood 1990; 76: 1908-1923.
8. Tsubata T, Wu J, Honjo T. B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 1993; 364: 645-648.
9. Foy TM, Laman JD, Ledbetter JA, Aruffo A, Claassen E, Nolle RJ. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J Exp Med 1994; 180; 157-163.
10. + T cells induced CD40-dependent proliferation of human B cell precursors. J Immunol 1994; 152: 1693-1701.
11. Van den Eertwegh AJM, Noelle RJ, Roy M, Shepherd DM, Aruffo A, Ledbetter JA, Boersma WJA, Claassen E. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J Exp Med 1993; 178: 1555-1565.
12. Fluckiger AC, Rossi JF, Bussel A, Bryon P, Banchereau J, Defrance T. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 1992; 80: 3173-3181.
13. Defrance T, Fluckiger A-C, Rossi J-F, Rousset F, Banchereau J. In vitro activation of B-CLL cells. Leuk Lymphoma 1991; 5 (Suppl.): 13-19.
14. Crawford DH, Catovsky D. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40 Immunology 1993; 80: 40-44.
15. Kluin-Nelemans JC, Beverstock GC, Mollevanger P, Wessels HW, Hoogendoorn E, Willemze R, Falkenburg JHF. Proliferation and cytogenetic analysis of hairy cell leukemia upon stimulation via the CD40 antigen. Blood 1994; 84: 3134-3141.
16. Johnson PWM, Watt SM, Betts DR, Davies D, Jordan S, Norton AJ, Lister TA. Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood 1993; 82: 1848-1857.
17. Uckun FM, Gajl-Peczalska K, Myers DE, Jaszcz W, Haissig S, Ledbetter JA. Temporal associataion of CD40 antigen expression with discrete stages of human B-cell ontogency and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood 1990; 76: 2449-2456.
18. Terstappen LWMM, Shah VO, Conrad MP, Recktenwald D, Loken MR. Discriminating between damaged and intact cells in fixed flow cytometric samples Cytometry 1988; 9: 477-484.
19. Berger F, Felman P, Sonet A, Salles G, Bastion Y, Bryon PA, Coiffier B. Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical features and outcome. Blood 1994; 83: 2829-2835.
20. Raffeld M, Jaffe ES. bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 1991; 78: 259-263.
21. Taylor CW, Grogan TM, Salmon SE. Effects of interleukin-4 of the in vitro growth of human lymphoid and plasma cell neoplasms. Blood 1990; 75: 1114-1118.
22. Freedman AS, Takvorian T, Anderson KC, Mauch P, Rabinowe SN, Blake K, Yeap B, Soiffer R, Coral F, Heflin L, Ritz J, Nadler LM. Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. J. Clin Oncol 1990; 8: 784-791.
23. Kishimoto T. The biology of interleukin-6. Blood 1989; 74: 1-10.
24. Lokhorst HM; Lamme T, De Smet M, Klein S, De Weger RA, Van Oers R, Bloem AC. Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood 1994; 84: 2269-2277.
25. Klein B, Zhang X-G, Lu Z-Y, Bataille R. Interleukin-6 in human multiple myeloma. Blood 1995; 85: 863-872.
26. Manabe A, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Pui C-H, Campana D. Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia. Blood 1994; 83: 1731-1737.
27. 1-positive acute lymphoblastic leukemia cells. Blood 1991; 78: 1574-1580.
28. Hermann F, Andreeff M, Gruss H-J, Brach MA, Lübbert M, Mertelsmann R. Interleukin-4 inhibits growth of multiple myelomas by suppressing interleukin-6 expression. Blood 1991; 78: 2070-2074.
29. Reittie JE, Hoffbrand AV. Interleukin-4 (IL-4) inhibits proliferation and spontaneous cytokine release by chronic lymphocytic leukaemia cells. Leukemia Res 1994; 18: 55-60.
30. Jansen JH, Fibbe WE, Wientjens GJHM, Van Damme J, Landegent JE, Willemze R, Kluin-Nelemans JC. Interleukin-4 down-regulates the expression of CD14 and the production of interleukin-6 in acute myeloid leukemia cells. Lymphokine Cytokine Res 1991; 10: 457-461.
31. Jansen JH, Fibbe WE, Wientjens GJHM, Willemze R, Kluin-Nelemans JC. Inhibitory effect of interleukin-4 on the proliferation of acute myeloid leukemia cells with myelo-monocytic differentiation (AML-M4/M5); the role of interleukin-6. Leukemia 1993; 7: 643-645.